26
Total investments
3
Early stage
9
Mid stage
4
Late stage
11y
Years active
Portfolio
22 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2026
Talin is the operating system for sales and client delivery. Made exclusively for staffing & recruitment agencies.
Outbound is the key driver to your business. Its how you engage candidates and how you start relationships with hiring managers; but thousands of agencies globally still use fragmented tools that arent made for them, dont integrate with their ATS, and offer generic AI that isnt trained on agency operations.
You invest all of your time and energy into BD, only to stop doing BD when things get busy. Before you know it, your pipeline is dry and you finish working on your roles, so you reluctantly get back to doing BD.
Talin breaks the cycle. Were built exclusively for staffing & recruitment agencies, integrate natively with your ATS, and run AI trained on how agency operations actually work. So BD keeps moving even when delivery gets busy. So your pipeline stays full whether youre working a role or building one.
Sales and client delivery, in one workspace. Try Talin free at talin.ai.
Board Observer
Sep 2025
Innodem Neurosciences is committed to improving the effectiveness and quality of life and care of patients with neurological problems.
Innodem works with the pharmaceutical industry, leading medical professionals, and artificial intelligence experts to develop and promote Eye Movement Biomarkers (EMBs) & Gaze Mapping Biomarkers (GMBs) as important clinical assessment tools in the field of neurology. It is building a series of disease-specific tests embodied in an intuitive App that captures EMB & GMB data. The vision is that over time, while leveraging the latest advances in machine and deep learning, this EMB/GMB platform will assist users to accurately diagnose and monitor neurological disorders affecting eye-movements or cognition such as multiple sclerosis, Alzheirmer’s, Parkinson’s or related disorders, Frontotemporal dementia, Cancer-related cognitive impairment (Chemo Brain) and many others.
Investor
Dec 2024
We strive to revolutionize health and safety for manual workers.
How ?
We prevent injuries and fatigue in industries where physical work is important by using smart and supportive wearables.
Investor
Dec 2024
Innospera is a privately-owned biotech company near clinical stage, developing small molecule modulators of 7-transmembrane receptors involved in a broad range of chronic and fibrotic conditions. The company’s lead drug candidates target key G-protein coupled receptors (GPCR) involved in fibroaging and inflammaging, including idiopathic pulmonary fibrosis (IPF), a condition with dire short-term prognosis. Innospera also develops multiple other modulators with promising potency in other medical conditions with pressing unmet needs. For more information, visit innospera.com
Investor
Oct 2024
Only 30% of candidates have the soft skills needed for job success—and HiringBranch identifies them before you even meet them.
Using responsible native AI, our assessments measure skills by role through tailored, open-ended voice and chat conversations with 98% accuracy. Start evaluating candidates effortlessly and hire top performers with confidence, every time.
Fortune 1000s and contact centers using HiringBranch have reduced interview time by over 80% while achieving mis-hire rates as low as 1%.
Our entire organization is dedicated to operating fairly, fostering diversity and inclusion globally through consistent, unbiased technology.
Investor
Oct 2023
Saguaro offers next-generation cell culture products that help scientists improve drug discovery success.
ChromaLive is a first-of-a-kind non-toxic dye. It allows the generation of unique phenotypic signatures from microscopy images of cells, and the quantification of disease-relevant phenotypes like cellular apoptosis, stress, autophagy, and more. With its unique add-and-mix feature, ChromaLive is ideal for automation workflows, live cell painting, 3D cultures, weeks-long kinetic imaging, and patient-derived cells.
We are passionate about new technologies that can improve human health. We believe that by making disruptive technologies available to drug developers around the globe, new therapies will become available to patients at a faster pace.
Investor & Board Observer
Sep 2023
BioIntelligence Technologies Inc. improves industrial bioprocesses in real-time for higher throughput, reproducibility, and profitability.
𝐁𝐢𝐨𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞’𝐬 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫𝐬 are producers of industrial biochemical, biofuel, food additives, biofertilizers, alternative proteins, cosmetics, biologics, etc. Actually, any production using microorganisms in a tank. They use the BioIntelligence Analytics Solution™ to de-risk bioprocess scale-ups and maximize full-scale profitability while increasing confidence in product quality.
𝐓𝐡𝐞 𝐁𝐢𝐨𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐬 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧™ 𝐢𝐬 𝐚 𝐭𝐮𝐫𝐧𝐤𝐞𝐲 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 developed by our team to measure in-line the metabolic activity of bacteria, yeast, molds, and cells in fermenters and bioreactors, and to perform advanced customized analytics in real-time, providing key performance indicators to operators and plant managers through customizable dashboards.
With the BioIntelligence Analytics Solution™, 𝐨𝐩𝐞𝐫𝐚𝐭𝐨𝐫𝐬 can eliminate process deviations, anticipate contaminations and infections, and maximize productivity in real-time. In a nutshell, operators take better decisions faster, increasing overall conversion yield and throughput of industrial bioprocesses.
𝐏𝐥𝐚𝐧𝐭 𝐦𝐚𝐧𝐚𝐠𝐞𝐫𝐬 𝐚𝐧𝐝 𝐑&𝐃 automatically learn from the analytics applied on a series of industrial productions, enabling them to find the root cause of variability and of bad batches, moving toward the ideal batch.
♦ Heres 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 to get a short 15-30 minute meeting where we’ll share with you how it works, and how it improves throughput and profitability of fermentation and cell cultures facilities:
https://calendly.com/leif-at-biointelligence/30min
Investor
Jan 2022
FRAMEWORK was founded in 2018 and has set the benchmark for active capital investing for early-stage companies. FRAMEWORK combines a unique, data-driven model with a high-touch collaborative engagement approach designed to assist Founders and CEOs in high-growth markets to scale while becoming better, smarter and more prepared for the next phase of growth.
FRAMEWORK Partners provide cutting-edge resources, opportunities and top-tier, empathetic counsel to Founders–becoming a trusted partner on the scaling journey. Partners Peter Misek, Ajay Gopal and Jean-Michel Texier, make use of a collaborative model of working that leverages decades of experience building, launching and reimagining businesses to the benefit of the FRAMEWORK portfolio.
FRAMEWORK primarily invests in Series A and Series B technology companies that have a strong purpose and mission to change the world for the better. The Startup Scorecard and Investor Network, accessible to all investors and Founders, aim to reinvent the early-stage ecosystem, eliminate bias in the investment process and empower Founders with the data they need to assess performance and drive growth. Visit our website to learn more and to benefit from the Startup Scorecard and Investor Network.
Investor
Nov 2021
At Depix, were on a mission to reshape the automotive design landscape through the fusion of creativity and cutting-edge technology. Our game-changing image-generative enterprise tool is poised to revolutionize automotive design, introducing a new era of innovation.
In a world where time and innovation are paramount, weve identified the hurdles faced by the automotive design industry. Cumbersome processes spanning over 10 weeks hinder creativity, while hidden costly errors don’t show up until the prototyping stage.
Empowering designers, our tool curates endless designs while maintaining meticulous control, ensuring each creation embodies your brands essence.
Imagine fully HDR-rendered designs materializing in just 3 hours. Yes, its possible. With Depix, the boundary between imagination and reality dissolves, and your creations emerge with unprecedented speed and beauty.
Ready to witness the future of automotive design? Join our waitlist now for an exclusive demo of our transformative tool. Welcome to the revolution.
Investor
Jul 2021
We bring optimization on the factory shop floor.
JITbase was founded in 2016 in Montreal, Canada to help manufacturing companies move to Industry 4.0.
JITbase is smart manufacturing software that uses machine data and information from CNC programs to calculate the optimal sequence of machinist activities on the shop floor.
The Optimal Path System (OPS) is based on algorithms that calculate in real-time what should happen in production in order to maximize the availability rate of the fleet of machines. Like GPS in a car that indicates where to go, OPS tells the machinist which machine he should tend to next. Whether manual intervention (setup, tool change, inspection etc.) is required or an unplanned stop occurs, the machinist is proactive and knows where and when he must be present. Machinists manage more CNC machines and make informed decisions that lead to increased uptime.
Investor
Jun 2021
Since 2015, CentrixOne has carved an enviable reputation for being a simple, intuitive, and affordable all-in-one CRM and marketing automation solution. Based in Montreal, CentrixOne has quickly become Quebecs leading provider of scalable CRM solutions for small- and medium-sized businesses.
Spearheaded by a multidisciplinary team of sales, marketing, and IT experts, CentrixOne believes that SMBs deserve a complete and easy-to-use CRM that will shift their business growth into 5th gear. Our CRM enables companies to structure, develop, and carry out results-driven sales and marketing initiatives. Ditch the CRM complexity and focus on your core business—and market expansion.
More info:
CRM: https://www.centrix.one/en/crm-for-small-and-medium-business/
Investor
Jun 2021
Kinetyx™ develops in-shoe sensor-based solutions for a broad range of sports and performance applications. Kinetyx’s sensory insoles' unique form factor and world-leading research grade sensor technology, allow it to measure human activity out in the real world to power a broad range of performance and readiness insights that have never before been possible.
Investor & Board Observer
Dec 2020
Sense Neuro Diagnostics is developing non-invasive technology that enables rapid, comprehensive detection of stroke (by subtype) and traumatic brain injury in a field environment, and continuous monitoring of brain injury in hospital.
Investor
Jul 2020
SeamlessMD provides the #1 digital patient engagement platform used by health systems to elevate the patient experience, improve outcomes and lower costs. Patients access digital care plans on their smartphones, tablets or computers and are guided through their health conditions or treatments via reminders, education and progress tracking. Providers receive alerts, monitor patients and access analytics to deliver better care. SeamlessMD is directly integrated with Epic and Cerner. Health systems such as Stanford Health Care, Rush University Medical Center and UAB Health System use SeamlessMD to improve patient satisfaction while reducing hospital length of stay, readmissions, and costs.
For more information and to see SeamlessMD in action, please visit: http://www.seamless.md.
Show all 22 investments ↓
Experience · 33 entries
All (33)
Investments (26)
Founder (1)
Board (8)
2026
Investor
Jun 2026
Talin is the operating system for sales and client delivery. Made exclusively for staffing & recruitment agencies.
Outbound is the key driver to your business. Its how you engage candidates and how you start relationships with hiring managers; but thousands of agencies globally still use fragmented tools that arent made for them, dont integrate with their ATS, and offer generic AI that isnt trained on agency operations.
You invest all of your time and energy into BD, only to stop doing BD when things get busy. Before you know it, your pipeline is dry and you finish working on your roles, so you reluctantly get back to doing BD.
Talin breaks the cycle. Were built exclusively for staffing & recruitment agencies, integrate natively with your ATS, and run AI trained on how agency operations actually work. So BD keeps moving even when delivery gets busy. So your pipeline stays full whether youre working a role or building one.
Sales and client delivery, in one workspace. Try Talin free at talin.ai.
2025
Board Observer
Sep 2025
Innodem Neurosciences is committed to improving the effectiveness and quality of life and care of patients with neurological problems.
Innodem works with the pharmaceutical industry, leading medical professionals, and artificial intelligence experts to develop and promote Eye Movement Biomarkers (EMBs) & Gaze Mapping Biomarkers (GMBs) as important clinical assessment tools in the field of neurology. It is building a series of disease-specific tests embodied in an intuitive App that captures EMB & GMB data. The vision is that over time, while leveraging the latest advances in machine and deep learning, this EMB/GMB platform will assist users to accurately diagnose and monitor neurological disorders affecting eye-movements or cognition such as multiple sclerosis, Alzheirmer’s, Parkinson’s or related disorders, Frontotemporal dementia, Cancer-related cognitive impairment (Chemo Brain) and many others.
2024
Investor
Dec 2024
We strive to revolutionize health and safety for manual workers.
How ?
We prevent injuries and fatigue in industries where physical work is important by using smart and supportive wearables.
Investor
Dec 2024
Innospera is a privately-owned biotech company near clinical stage, developing small molecule modulators of 7-transmembrane receptors involved in a broad range of chronic and fibrotic conditions. The company’s lead drug candidates target key G-protein coupled receptors (GPCR) involved in fibroaging and inflammaging, including idiopathic pulmonary fibrosis (IPF), a condition with dire short-term prognosis. Innospera also develops multiple other modulators with promising potency in other medical conditions with pressing unmet needs. For more information, visit innospera.com
Investor
Oct 2024
Only 30% of candidates have the soft skills needed for job success—and HiringBranch identifies them before you even meet them.
Using responsible native AI, our assessments measure skills by role through tailored, open-ended voice and chat conversations with 98% accuracy. Start evaluating candidates effortlessly and hire top performers with confidence, every time.
Fortune 1000s and contact centers using HiringBranch have reduced interview time by over 80% while achieving mis-hire rates as low as 1%.
Our entire organization is dedicated to operating fairly, fostering diversity and inclusion globally through consistent, unbiased technology.
Show all 33 entries ↓
Investment activity
2015–2026 · 26 investments
Recent (last 2 years)Earlier
